VRDN
Viridian Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.92
−0.17%0
Insider buys (3m)
1
Insider sells (3m)
-$245.0K
Net value (3m)
+44.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 20, 2026 | Tousignant Jennifer · officer: Chief Legal Officer | M-Exempt | 10,000 | $14 |
| Aug 20, 2026 | Tousignant Jennifer · officer: Chief Legal Officer | Sale | 10,000 | $25 |
| Aug 18, 2026 | Tripuraneni Radhika · officer: Chief Medical Officer | M-Exempt | 40,000 | $13 |
| Jul 2, 2026 | CAIN CHRISTOPHER W. · director | A-Award | 32,341 | $18 |
| Jul 2, 2026 | Morris Arlene · director | A-Award | 32,341 | $18 |
| Jul 2, 2026 | Kiselak Tomas · director | A-Award | 32,341 | $18 |
| Jul 2, 2026 | Gheuens Sarah · director | A-Award | 32,341 | $18 |
| Jul 2, 2026 | Moses Jennifer K. · director | A-Award | 32,341 | $18 |
| Jul 2, 2026 | Ajer Jeffrey Robert · director | A-Award | 32,341 | $18 |
| May 13, 2026 | Fairmount Funds Management LLC · director, 10 percent owner: | Purchase | 1,176,470 | $17 |
| Mar 9, 2026 | Harmon Seth · officer: Chief Financial Officer | F-InKind | 2,031 | $30 |
| Mar 9, 2026 | Beetham Thomas W. · officer: Chief Operating Officer | F-InKind | 3,048 | $30 |
| Mar 9, 2026 | Tousignant Jennifer · officer: Chief Legal Officer | F-InKind | 1,675 | $30 |
| Mar 9, 2026 | Mahoney Stephen F. · director, officer: President and CEO | F-InKind | 7,408 | $30 |
| Mar 4, 2026 | Mahoney Stephen F. · officer: President and CEO | A-Award | 111,900 | $0.00 |
| Mar 4, 2026 | Tousignant Jennifer · officer: Chief Legal Officer | F-InKind | 1,724 | $29 |
| Mar 4, 2026 | Tousignant Jennifer · officer: Chief Legal Officer | A-Award | 23,850 | $0.00 |
| Mar 4, 2026 | Tousignant Jennifer · officer: Chief Legal Officer | M-Exempt | 5,169 | $0.00 |
| Mar 4, 2026 | Tousignant Jennifer · officer: Chief Legal Officer | A-Award | 119,300 | $30 |
| Mar 4, 2026 | Harmon Seth · officer: Chief Financial Officer | F-InKind | 2,091 | $29 |
| Mar 4, 2026 | Harmon Seth · officer: Chief Financial Officer | M-Exempt | 6,267 | $0.00 |
| Mar 4, 2026 | Harmon Seth · officer: Chief Financial Officer | A-Award | 102,850 | $30 |
| Mar 4, 2026 | Harmon Seth · officer: Chief Financial Officer | A-Award | 20,550 | $0.00 |
| Mar 4, 2026 | Beetham Thomas W. · officer: Chief Operating Officer | F-InKind | 3,138 | $29 |
| Mar 4, 2026 | Beetham Thomas W. · officer: Chief Operating Officer | M-Exempt | 9,409 | $0.00 |
| Mar 4, 2026 | Beetham Thomas W. · officer: Chief Operating Officer | A-Award | 176,550 | $30 |
| Mar 4, 2026 | Beetham Thomas W. · officer: Chief Operating Officer | A-Award | 35,300 | $0.00 |
| Mar 4, 2026 | Mahoney Stephen F. · officer: President and CEO | F-InKind | 7,627 | $29 |
| Mar 4, 2026 | Mahoney Stephen F. · officer: President and CEO | A-Award | 559,600 | $30 |
| Mar 4, 2026 | Mahoney Stephen F. · officer: President and CEO | M-Exempt | 18,357 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 98Increased 177Reduced 122Sold out 53
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 16,604,740 | Aug 13, 2026 |
| FMR LLC | Increased | 15,379,377 | May 15, 2026 |
| BlackRock, Inc. | Increased | 8,551,488 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 7,831,475 | May 13, 2026 |
| Bellevue Group AG | Increased | 6,731,909 | Aug 14, 2026 |
| BELLEVUE GROUP AG | Increased | 6,726,144 | May 15, 2026 |
| Paradigm Biocapital Advisors LP | Increased | 6,723,788 | Aug 14, 2026 |
| Kynam Capital Management, LP | Increased | 6,453,877 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 6,124,976 | Aug 7, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 5,748,410 | Aug 14, 2026 |
| Fairmount Funds Management LLC | Increased | 5,090,928 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 4,672,885 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,576,860 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4,167,201 | May 15, 2026 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | Unchanged | 3,914,458 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 20, 2026